In individuals with type 1 diabetes, hypoglycemia is a common consequence of overinsulinization. Under conditions of insulin-induced hypoglycemia, glucagon is the most important stimulus for hepatic glucose production. In contrast, during euglycemia, insulin potently inhibits glucagon’s effect on the liver. The first aim of the present study was to determine whether low blood sugar augments glucagon’s ability to increase glucose production. Using a conscious catheterized dog model, we found that hypoglycemia increased glucagon’s ability to overcome the inhibitory effect of insulin on hepatic glucose production by almost 3-fold, an effect exclusively attributable to marked enhancement of the effect of glucagon on net glycogen breakdown. To investigate the molecular mechanism by which this effect comes about, we analyzed hepatic biopsies from the same animals, and found that hypoglycemia resulted in a decrease in insulin signaling. Furthermore, hypoglycemia and glucagon had an additive effect on the activation of AMPK, which was associated with altered activity of the enzymes of glycogen metabolism.
Noelia Rivera, Christopher J. Ramnanan, Zhibo An, Tiffany Farmer, Marta Smith, Ben Farmer, Jose M. Irimia, Wanda Snead, Margaret Lautz, Peter J. Roach, Alan D. Cherrington
Title and authors | Publication | Year |
---|---|---|
Hepatic Metabolic Memory Triggered by AM Exposure to Glucagon Alters Afternoon Glucose Metabolism
Waterman HL, Smith MS, Farmer B, Yankey K, Howard T, Kraft G, Edgerton DS, Cherrington AD |
bioRxiv | 2025 |
Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes
D\u2019Souza NC, Aiken JA, Hoffman EG, Atherley SC, Champsi S, Aleali N, Shakeri D, El-Zahed M, Akbarian N, Nejad-Mansouri M, Bavani PZ, Liggins RL, Chan O, Riddell MC |
Frontiers in pharmacology | 2024 |
Integration of metabolic flux with hepatic glucagon signaling and gene expression profiles in the conscious dog
Coate KC, Ramnanan CJ, Smith M, Winnick JJ, Kraft G, Irimia-Dominguez J, Farmer B, Donahue EP, Roach PJ, Cherrington AD, Edgerton DS |
American journal of physiology. Endocrinology and metabolism | 2024 |
Short-term fasting lowers glucagon levels under euglycemic and hypoglycemic conditions in healthy humans
Shana Warner, Yufei Dai, Nicole Sheanon, Michael Yao, Rebecca Cason, Shahriar Arbabi, Shailendra Patel, Diana Lindquist, Jason Winnick |
JCI Insight | 2023 |
Biochemical Toxicological Study of Insulin Overdose in Rats: A Forensic Perspective.
Bian C, He X, Wang Q, Zheng Z, Zhang Y, Xiong H, Li Y, Zhao M, Li J |
Toxics | 2023 |
Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.
Rodgers RL |
Physiological Reports | 2022 |
In vitro generation of transplantable insulin-producing cells from canine adipose-derived mesenchymal stem cells.
Dang Le Q, Rodprasert W, Kuncorojakti S, Pavasant P, Osathanon T, Sawangmake C |
Scientific Reports | 2022 |
C-peptide enhances glucagon secretion in response to hyperinsulinemia under euglycemic and hypoglycemic conditions
Mary Courtney Moore, Shana O. Warner, Yufei Dai, Nicole Sheanon, Marta Smith, Ben Farmer, Rebecca L. Cason, Alan D. Cherrington, Jason J. Winnick |
JCI Insight | 2021 |
Liver glycogen-induced enhancements in hypoglycemic counterregulation require neuroglucopenia
SO Warner, AM Wadian, M Smith, B Farmer, Y Dai, N Sheanon, DS Edgerton, JJ Winnick |
American journal of physiology. Endocrinology and metabolism | 2021 |
The hepatic glucose-mobilizing effect of glucagon is not mediated by cyclic AMP most of the time
RL Rodgers |
American journal of physiology. Endocrinology and metabolism | 2021 |
Structural principles of insulin formulation and analog design: A century of innovation
MA Jarosinski, B Dhayalan, YS Chen, D Chatterjee, N Varas, MA Weiss |
Molecular Metabolism | 2021 |
Serum spexin concentration, body condition score and markers of obesity in dogs
PA Kolodziejski, E PruszynskaOszmalek, T Nowak, A Lukomska, M Sassek, J Wlodarek, L Nogowski, A Cieslak, KW Nowak |
Journal of Veterinary Internal Medicine | 2021 |
New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals
M Jarosinski, Y Chen, N Varas, B Dhayalan, D Chatterjee, M Weiss |
The Journal of clinical endocrinology and metabolism | 2021 |
The kinetics of glucagon action on the liver during insulin-induced hypoglycemia
C Pedersen, G Kraft, DS Edgerton, M Scott, B Farmer, M Smith, DC Laneve, PE Williams, LM Moore, AD Cherrington |
American journal of physiology. Endocrinology and metabolism | 2020 |
Dual treatment with a fixed ratio of glucagon and insulin increases the therapeutic window of insulin in diabetic rats
C Pedersen, SD Bouman, T Porsgaard, MM Rosenkilde, NK Roed |
Physiological Reports | 2018 |
Intraperitoneal, subcutaneous and intravenous glucagon delivery and subsequent glucose response in rats: a randomized controlled crossover trial
I Dirnena-Fusini, MK Åm, AL Fougner, SM Carlsen, SC Christiansen |
BMJ Open Diabetes Research & Care | 2018 |
Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog
JM Gregory, N Rivera, G Kraft, JJ Winnick, B Farmer, EJ Allen, EP Donahue, MS Smith, DS Edgerton, PE Williams, AD Cherrington |
American journal of physiology. Endocrinology and metabolism | 2017 |
Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis
Jason J. Winnick, Guillaume Kraft, Justin M. Gregory, Dale S. Edgerton, Phil Williams, Ian Hajizedah, Maahum Kamal, Marta Smith, Ben Farmer, scott melanie, Doss Neal, Patrick Donahue, eric allen, Alan Cherrington |
Journal of Clinical Investigation | 2016 |
Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials
Y Zheng, U Ceglarek, T Huang, L Li, J Rood, DH Ryan, GA Bray, FM Sacks, D Schwarzfuchs, J Thiery, I Shai, L Qi |
The American journal of clinical nutrition | 2016 |
Comparative Pharmacokinetic/Pharmacodynamic Study of Liquid Stable Glucagon Versus Lyophilized Glucagon in Type 1 Diabetes Subjects
JR Castle, JE Youssef, D Branigan, B Newswanger, P Strange, M Cummins, L Shi, S Prestrelski |
Journal of diabetes science and technology | 2016 |
Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments
L Hinshaw, A Mallad, CD Man, R Basu, C Cobelli, RE Carter, YC Kudva, A Basu |
American journal of physiology. Endocrinology and metabolism | 2015 |
A Novel Antihypoglycemic Role of Inducible Nitric Oxide Synthase in Liver Inflammatory Response Induced by Dietary Cholesterol and Endotoxemia
S Anavi, M Hahn-Obercyger, R Margalit, Z Madar, O Tirosh |
Antioxidants & Redox Signaling | 2013 |
Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism
MC Moore, MS Smith, VP Sinha, JM Beals, MD Michael, SJ Jacober, AD Cherrington |
Diabetes | 2013 |
Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver
CM Hasenour, ED Berglund, DH Wasserman |
Molecular and Cellular Endocrinology | 2012 |
Ectopic expression of glucagon receptor in skeletal muscles improves glucose homeostasis in a mouse model of diabetes
A Maharaj, L Zhu, F Huang, H Qiu, H Li, CY Zhang, T Jin, Q Wang |
Diabetologia | 2012 |
Physiologic action of glucagon on liver glucose metabolism
CJ Ramnanan, DS Edgerton, G Kraft, AD Cherrington |
Diabetes, Obesity and Metabolism | 2011 |
Safe Glycemic Management during Closed-Loop Treatment of Type 1 Diabetes: The Role of Glucagon, Use of Multiple Sensors, and Compensation for Stress Hyperglycemia
Ward WK, Castle JR, Youssef JE |
Journal of diabetes science and technology | 2011 |